+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Diabetic Eye Disease Devices Market by Product Type, End User, Indication, Technology - Global Forecast 2025-2030- Product Image
Diabetic Eye Disease Devices Market by Product Type, End User, Indication, Technology - Global Forecast 2025-2030- Product Image
Sale

Diabetic Eye Disease Devices Market by Product Type, End User, Indication, Technology - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 193 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6015430
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Diabetic Eye Disease Devices Market grew from USD 17.38 billion in 2023 to USD 18.92 billion in 2024. It is expected to continue growing at a CAGR of 9.56%, reaching USD 32.95 billion by 2030.

The diabetic eye disease devices market encompasses a range of medical equipment used for the diagnosis, monitoring, and treatment of eye conditions associated with diabetes, such as diabetic retinopathy and diabetic macular edema. These conditions can result in severe eye damage and blindness if left untreated, making the availability of effective devices essential. Applications span diagnostic tools like optical coherence tomography (OCT) and fundus cameras, alongside therapeutic devices such as laser equipment and vitrectomy machinery. End-users include hospitals, ophthalmology clinics, and specialty eye care centers. The market growth is primarily driven by the increasing global diabetic population, heightened health awareness, and technological advancements in diagnostic and treatment approaches. A strong push towards early and preventive eye care is encouraging innovation and investment, presenting opportunities for firms to penetrate emerging markets with cost-effective, portable, and user-friendly devices. However, growth barriers include high equipment costs, lack of skilled personnel in developing regions, and strict regulatory frameworks that can delay the product launch process. Key opportunities lie in the integration of artificial intelligence for enhanced image analysis and remote diagnostics, telemedicine approaches for greater reach, and developing multifunctional devices that offer both diagnostic and therapeutic capabilities. Market research suggests that focusing on personalized medicine and patient-centric solutions could provide competitive advantages. Limitations such as limited reimbursement policies and patient non-adherence to treatment plans pose significant challenges. Innovations focusing on simplified device designs, advanced imaging technologies, and digital health solutions to empower self-monitoring are highly promising areas for business growth. Moreover, collaboration with healthcare providers to improve patient compliance and accessibility, and addressing educational gaps among users, could further accelerate adoption. The market remains moderately competitive, with notable potential for novel entrants endowed with breakthrough technologies and strong value propositions to capture significant market share.

Understanding Market Dynamics in the Diabetic Eye Disease Devices Market

The Diabetic Eye Disease Devices Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing adoption of telemedicine and digital health solutions for diabetic eye care
    • Collaborations between key industry players to innovate and expand market reach
    • Growing investments in research and development for diabetic retinopathy treatments
    • Expansion of healthcare infrastructure in emerging markets increasing access to care
  • Market Restraints
    • High capital costs and product recalls of diabetic eye disease devices
  • Market Opportunities
    • Cutting-edge AI-driven platforms for accurate diabetic eye disease diagnostics
    • Affordable and portable screening tools for underserved diabetic populations
    • Development of non-invasive therapeutic devices for diabetic retinopathy treatment
  • Market Challenges
    • Limited availability of skilled professionals and technical limitations with devices

Exploring Porter’s Five Forces for the Diabetic Eye Disease Devices Market

Porter’s Five Forces framework further strengthens the insights of the Diabetic Eye Disease Devices Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Diabetic Eye Disease Devices Market

External macro-environmental factors deeply influence the performance of the Diabetic Eye Disease Devices Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Diabetic Eye Disease Devices Market

The Diabetic Eye Disease Devices Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Diabetic Eye Disease Devices Market

The Diabetic Eye Disease Devices Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Diabetic Eye Disease Devices Market

The Diabetic Eye Disease Devices Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Diabetic Eye Disease Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alcon Inc., Allergan plc, Bayer AG, BD (Becton, Dickinson and Company), Carl Zeiss AG, Clearside Biomedical, Inc., F. Hoffmann-La Roche Ltd, Genentech, Inc., GlaxoSmithKline plc, Iveric Bio, Inc., Novartis AG, Ocular Therapeutix, Inc., Optos plc, Pfizer Inc., Regeneron Pharmaceuticals, Inc., Sanofi S.A., Santen Pharmaceutical Co., Ltd., Topcon Corporation, and Vitreoretinal Technologies, Inc..

Market Segmentation & Coverage

This research report categorizes the Diabetic Eye Disease Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product Type
    • Diagnostic Devices
      • Fluorescein Angiography
      • Fundus Cameras
      • Optical Coherence Tomography (OCT) Scanners
    • Treatment Devices
      • Intraocular Lenses (IOLs)
      • Laser Systems
        • Photocoagulation Lasers
        • Photodisruption Lasers
      • Vitrectomy Devices
  • End User
    • Ambulatory Surgical Centers
    • Hospitals
    • Ophthalmic Clinics
  • Indication
    • Diabetic Macular Edema (DME)
      • Diffuse DME
      • Focal DME
    • Diabetic Retinopathy
      • Non-Proliferative Diabetic Retinopathy
      • Proliferative Diabetic Retinopathy
  • Technology
    • Intravitreal Injections
    • Laser Therapy
    • Vitrectomy
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing adoption of telemedicine and digital health solutions for diabetic eye care
5.1.1.2. Collaborations between key industry players to innovate and expand market reach
5.1.1.3. Growing investments in research and development for diabetic retinopathy treatments
5.1.1.4. Expansion of healthcare infrastructure in emerging markets increasing access to care
5.1.2. Restraints
5.1.2.1. High capital costs and product recalls of diabetic eye disease devices
5.1.3. Opportunities
5.1.3.1. Cutting-edge AI-driven platforms for accurate diabetic eye disease diagnostics
5.1.3.2. Affordable and portable screening tools for underserved diabetic populations
5.1.3.3. Development of non-invasive therapeutic devices for diabetic retinopathy treatment
5.1.4. Challenges
5.1.4.1. Limited availability of skilled professionals and technical limitations with devices
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Diabetic Eye Disease Devices Market, by Product Type
6.1. Introduction
6.2. Diagnostic Devices
6.2.1. Fluorescein Angiography
6.2.2. Fundus Cameras
6.2.3. Optical Coherence Tomography (OCT) Scanners
6.3. Treatment Devices
6.3.1. Intraocular Lenses (IOLs)
6.3.2. Laser Systems
6.3.2.1. Photocoagulation Lasers
6.3.2.2. Photodisruption Lasers
6.3.3. Vitrectomy Devices
7. Diabetic Eye Disease Devices Market, by End User
7.1. Introduction
7.2. Ambulatory Surgical Centers
7.3. Hospitals
7.4. Ophthalmic Clinics
8. Diabetic Eye Disease Devices Market, by Indication
8.1. Introduction
8.2. Diabetic Macular Edema (DME)
8.2.1. Diffuse DME
8.2.2. Focal DME
8.3. Diabetic Retinopathy
8.3.1. Non-Proliferative Diabetic Retinopathy
8.3.2. Proliferative Diabetic Retinopathy
9. Diabetic Eye Disease Devices Market, by Technology
9.1. Introduction
9.2. Intravitreal Injections
9.3. Laser Therapy
9.4. Vitrectomy
10. Americas Diabetic Eye Disease Devices Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Diabetic Eye Disease Devices Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Diabetic Eye Disease Devices Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. DIABETIC EYE DISEASE DEVICES MARKET RESEARCH PROCESS
FIGURE 2. DIABETIC EYE DISEASE DEVICES MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 9. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 13. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. DIABETIC EYE DISEASE DEVICES MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. DIABETIC EYE DISEASE DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. DIABETIC EYE DISEASE DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. DIABETIC EYE DISEASE DEVICES MARKET DYNAMICS
TABLE 7. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY FLUORESCEIN ANGIOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY FUNDUS CAMERAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY (OCT) SCANNERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INTRAOCULAR LENSES (IOLS), BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PHOTOCOAGULATION LASERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PHOTODISRUPTION LASERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY VITRECTOMY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY OPHTHALMIC CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIFFUSE DME, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY FOCAL DME, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY NON-PROLIFERATIVE DIABETIC RETINOPATHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PROLIFERATIVE DIABETIC RETINOPATHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INTRAVITREAL INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY VITRECTOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
TABLE 45. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
TABLE 64. BRAZIL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 66. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 67. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 68. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 69. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
TABLE 70. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 72. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
TABLE 73. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 74. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 75. MEXICO DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 76. MEXICO DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 77. MEXICO DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 78. MEXICO DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
TABLE 79. MEXICO DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. MEXICO DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 81. MEXICO DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
TABLE 82. MEXICO DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 83. MEXICO DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 94. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 96. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 97. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
TABLE 98. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 100. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
TABLE 101. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 102. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 103. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 104. AUSTRALIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 105. AUSTRALIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 106. AUSTRALIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 107. AUSTRALIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
TABLE 108. AUSTRALIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. AUSTRALIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 110. AUSTRALIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
TABLE 111. AUSTRALIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 112. AUSTRALIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 113. CHINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 114. CHINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 115. CHINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 116. CHINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
TABLE 117. CHINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. CHINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 119. CHINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
TABLE 120. CHINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 121. CHINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 122. INDIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 123. INDIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 124. INDIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 125. INDIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
TABLE 126. INDIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. INDIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 128. INDIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
TABLE 129. INDIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 130. INDIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 131. INDONESIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 132. INDONESIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 133. INDONESIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 134. INDONESIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
TABLE 135. INDONESIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 136. INDONESIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 137. INDONESIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
TABLE 138. INDONESIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 139. INDONESIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 140. JAPAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 141. JAPAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 142. JAPAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 143. JAPAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
TABLE 144. JAPAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. JAPAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 146. JAPAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
TABLE 147. JAPAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 148. JAPAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 149. MALAYSIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 150. MALAYSIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 151. MALAYSIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 152. MALAYSIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
TABLE 153. MALAYSIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. MALAYSIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 155. MALAYSIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
TABLE 156. MALAYSIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 157. MALAYSIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 158. PHILIPPINES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 159. PHILIPPINES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 160. PHILIPPINES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 161. PHILIPPINES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
TABLE 162. PHILIPPINES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. PHILIPPINES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 164. PHILIPPINES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
TABLE 165. PHILIPPINES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 166. PHILIPPINES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 167. SINGAPORE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 168. SINGAPORE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 169. SINGAPORE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 170. SINGAPORE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
TABLE 171. SINGAPORE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. SINGAPORE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 173. SINGAPORE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
TABLE 174. SINGAPORE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 175. SINGAPORE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 176. SOUTH KOREA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 177. SOUTH KOREA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 178. SOUTH KOREA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 179. SOUTH KOREA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
TABLE 180. SOUTH KOREA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. SOUTH KOREA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 182. SOUTH KOREA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
TABLE 183. SOUTH KOREA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 184. SOUTH KOREA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 185. TAIWAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 186. TAIWAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 187. TAIWAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 188. TAIWAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
TABLE 189. TAIWAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. TAIWAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 191. TAIWAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
TABLE 192. TAIWAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 193. TAIWAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 194. THAILAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 195. THAILAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 196. THAILAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 197. THAILAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
TABLE 198. THAILAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 199. THAILAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 200. THAILAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
TABLE 201. THAILAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 202. THAILAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 203. VIETNAM DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 204. VIETNAM DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 205. VIETNAM DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 206. VIETNAM DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
TABLE 207. VIETNAM DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 208. VIETNAM DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 209. VIETNAM DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
TABLE 210. VIETNAM DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 211. VIETNAM DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 222. DENMARK DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 223. DENMARK DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 224. DENMARK DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 225. DENMARK DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
TABLE 226. DENMARK DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. DENMARK DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 228. DENMARK DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
TABLE 229. DENMARK DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 230. DENMARK DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 231. EGYPT DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 232. EGYPT DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 233. EGYPT DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 234. EGYPT DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
TABLE 235. EGYPT DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 236. EGYPT DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 237. EGYPT DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
TABLE 238. EGYPT DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 239. EGYPT DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 240. FINLAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 241. FINLAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 242. FINLAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 243. FINLAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
TABLE 244. FINLAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 245. FINLAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 246. FINLAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
TABLE 247. FINLAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 248. FINLAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 249. FRANCE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 250. FRANCE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 251. FRANCE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 252. FRANCE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
TABLE 253. FRANCE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 254. FRANCE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 255. FRANCE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
TABLE 256. FRANCE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 257. FRANCE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 258. GERMANY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 259. GERMANY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 260. GERMANY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 261. GERMANY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
TABLE 262. GERMANY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 263. GERMANY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 264. GERMANY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
TABLE 265. GERMANY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 266. GERMANY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 267. ISRAEL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 268. ISRAEL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 269. ISRAEL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 270. ISRAEL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
TABLE 271. ISRAEL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 272. ISRAEL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 273. ISRAEL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
TABLE 274. ISRAEL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 275. ISRAEL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 276. ITALY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 277. ITALY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 278. ITALY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 279. ITALY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
TABLE 280. ITALY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 281. ITALY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 282. ITALY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
TABLE 283. ITALY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 284. ITALY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 285. NETHERLANDS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 286. NETHERLANDS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 287. NETHERLANDS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 288. NETHERLANDS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
TABLE 289. NETHERLANDS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 290. NETHERLANDS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 291. NETHERLANDS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
TABLE 292. NETHERLANDS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 293. NETHERLANDS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 294. NIGERIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 295. NIGERIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 296. NIGERIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 297. NIGERIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
TABLE 298. NIGERIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 299. NIGERIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 300. NIGERIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
TABLE 301. NIGERIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
TABLE 302. NIGERIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 303. NORWAY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 304. NORWAY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 305. NORWAY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
TABLE 306. NORWAY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
TABLE 307. NORWAY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 308. NORWAY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE

Companies Mentioned

The leading players in the Diabetic Eye Disease Devices Market, which are profiled in this report, include:
  • Abbott Laboratories
  • Alcon Inc.
  • Allergan plc
  • Bayer AG
  • BD (Becton, Dickinson and Company)
  • Carl Zeiss AG
  • Clearside Biomedical, Inc.
  • F. Hoffmann-La Roche Ltd
  • Genentech, Inc.
  • GlaxoSmithKline plc
  • Iveric Bio, Inc.
  • Novartis AG
  • Ocular Therapeutix, Inc.
  • Optos plc
  • Pfizer Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Sanofi S.A.
  • Santen Pharmaceutical Co., Ltd.
  • Topcon Corporation
  • Vitreoretinal Technologies, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages193
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 18.92 Billion
Forecasted Market Value ( USD ) by 2030 $ 32.95 Billion
Compound Annual Growth Rate9.5%
Regions CoveredGlobal
No. of Companies Mentioned20

Related Topics

Related Reports

Diabetic Eye Disease Devices - Global Strategic Business Report - Product Image

Diabetic Eye Disease Devices - Global Strategic Business Report

  • Report
  • 270 Pages
  • Global
From
Diabetic Eye Disease - Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

Diabetic Eye Disease - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 200 Pages
  • Global
From
Eye Drops and Lubricants Market Report by Type (Antibiotics, Hormones, Artificial Tears, and Others), Application (Eye Diseases, Eye Care), and Region 2024-2032 - Product Image

Eye Drops and Lubricants Market Report by Type (Antibiotics, Hormones, Artificial Tears, and Others), Application (Eye Diseases, Eye Care), and Region 2024-2032

  • Report
  • 148 Pages
  • Global
From
Thyroid Eye Disease (TED) - Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

Thyroid Eye Disease (TED) - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 200 Pages
  • Global
From
Thyroid Eye Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Image

Thyroid Eye Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • 131 Pages
  • Global
From

About the Diabetic Eye Disease Devices Market

Within the realm of optics, the diabetic eye disease devices market encompasses a range of medical devices and equipment designed for the screening, diagnosis, management, and treatment of eye conditions associated with diabetes. One of the most common complications of diabetes is diabetic retinopathy, which can lead to deterioration in vision and, ultimately, blindness if left untreated. Consequently, the market for diabetic eye disease devices includes but is not limited to fundus cameras, OCT (optical coherence tomography) devices, fluorescein angiography equipment, laser treatment devices, and retinal screening systems. These devices aid eye care professionals in monitoring the progression of retinal diseases, facilitating early detection, and providing therapeutic interventions that can preserve vision. Innovations in this sector often focus on enhancing imaging capabilities, improving patient comfort, and integrating with health informatics systems to streamline the workflow in ophthalmic clinics. Several notable companies operating within the diabetic eye disease devices market include Topcon Corporation, which provides imaging and laser systems for eye care; Carl Zeiss AG, known for their optical and optoelectronic technology; and Optos plc, which offers ultra-widefield retinal imaging devices. Other key players in this sector are Canon Inc., focusing on digital imaging, and NIDEK Co., Ltd., which manufactures comprehensive eye examination and treatment devices. These companies are among the leaders in advancing the technology that supports eye care professionals in managing diabetes-related eye diseases. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.